FDA 510(k)

OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT

K-Number: K955139 · 1996-02-12

Decision Date1996-02-12

Product CodeJMO

Advisory CommitteeCH

DecisionSubstantially Equivalent

Device Summary

OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT is the device name listed in this FDA 510(k) record. The listed applicant is Olympus America, Inc.. It received FDA 510(k) clearance on 1996-02-12 under 510(k) number K955139. The device is classified under product code JMO. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT?

OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT is a medical device that received FDA 510(k) clearance on 1996-02-12. The listed applicant is Olympus America, Inc.. The 510(k) number is K955139.

When did OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT receive FDA 510(k) clearance?

OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT received FDA 510(k) clearance on 1996-02-12, under 510(k) number K955139.

Who is the listed applicant for OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT?

The FDA 510(k) record lists Olympus America, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT?

The FDA product code for OLYMPUS UNSATURATED IRON BINDING CAPACITY REAGENT is JMO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Olympus America, Inc. as applicant

K111788ENDOEYE HD II K081615OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN K073487OLYMPUS IGM REAGENT K073490OLYMPUS IGG REAGENT K073489OLYMPUS IGA REAGENT K062862OLYMPUS URIC ACID REAGENT, MODEL OSR6X98

View all 149 devices →

Related Devices (Code: JMO)

K113438ACE DIRECT TOTALIRON-BINDING CAPACITY (TIBC) REAGENT, ACE SERUM IRON REAGENT, ACE LIPASE REAGENTAlfa Wassermann Diagnostic Technologies, Inc.K061464VITROS CHEMISTRY PRODUCTS TIBC KIT, MODEL 886 7541; CALIBRATOR KIT 4, MODEL 120 4668Ortho-Clinical Diagnostics, Inc.K052867VITROS CHEMISTRY PRODUCTS DTIBC REAGENTOrtho-Clinical Diagnostics, Inc.K041793OLYMPUS UNSATURATED IRON BINDING CAPCITY REAGENT, OSR6124/0SR6524Olympus America, Inc.K013102WIENER LAB. FER-COLOR TRANSFERRINA, MODEL AUX. REAGENTS FOR 25 SAMPLES CAT. 1492002Wiener Laboratories Saic K012340BAYER ADVIA SYSTEM; UNSATURATED IRON BINDING CAPACITY (UIBC)Bayer Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.